Masimo Corp.

Masimo Corp. is a global medical technology company that develops, manufactures, and markets a variety of non-invasive patient monitoring technologies, sensors, and medical devices for use at home and in medical settings. Masimo has its US headquarters in Irvine, California, and its international headquarters in Neuchatel, Switzerland. The firm was founded in 1989. One of the company’s main products is the Masimo Signal Extraction Technology (SET) pulse oximetry, a system that allows for a more accurate measurement of oxygen saturation than traditional methods of pulse oximetry, allowing for higher-quality patient monitoring, improved patient safety, and better outcomes. The system incorporates remote alarm and monitoring solutions and software. Masimo reaches a worldwide audience, employing more than 4,600 people around the globe. The firm sells its products to a wide range of customers, including hospitals, emergency medical service providers, home care providers, long-term care facilities, physician offices, veterinarians, consumers, and original equipment manufacturers. Sales are made through a network of distributors as well as via the firm’s own direct sales force. The firm is listed on the NASDAQ under the ticker MASI. To receive regular news and real-time updates on the value of Masimo Corp shares, simply add MASI stock to your watchlist on eToro.